65 related articles for article (PubMed ID: 14663275)
1. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
[TBL] [Abstract][Full Text] [Related]
2. Survival Benefit of Myeloablative Therapy with Autologous Stem Cell Transplantation in High-Risk Neuroblastoma: A Systematic Literature Review.
Żebrowska U; Balwierz W; Wechowski J; Wieczorek A
Target Oncol; 2024 Mar; 19(2):143-159. PubMed ID: 38401028
[TBL] [Abstract][Full Text] [Related]
3. Local control and toxicity outcomes following consolidative radiation therapy in patients with high-risk neuroblastoma: a 20-year experience at a single center.
Jang JY; Park JH; Kim YJ; Im HJ; Koh KN; Kim H; Kang SH; Kim HU; Ahn SD
Turk J Pediatr; 2024; 66(1):99-109. PubMed ID: 38523384
[TBL] [Abstract][Full Text] [Related]
4. Stage 4 s neuroblastoma: features, management and outcome of 268 cases from the Italian Neuroblastoma Registry.
De Bernardi B; Di Cataldo A; Garaventa A; Massirio P; Viscardi E; Podda MG; Castellano A; D'Angelo P; Tirtei E; Melchionda F; Vetrella S; De Leonardis F; D'Ippolito C; Tondo A; Nonnis A; Erminio G; Gigliotti AR; Mazzocco K; Haupt R
Ital J Pediatr; 2019 Jan; 45(1):8. PubMed ID: 30634996
[TBL] [Abstract][Full Text] [Related]
5. Local MRI before and after Tumor Resection in Neuroblastoma: Impact of Residual Disease on Event Free Survival.
Schäfer JF; Gassenmaier S; Warmann S; Urla C; Frauenfeld L; Flaadt T; Chaika M; Esser M; Tsiflikas I; Timmermann B; Fuchs J
J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068349
[TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field.
Liu KX; Shaaban SG; Chen JJ; Bagatell R; Lerman BJ; Catalano PJ; DuBois SG; Shusterman S; Ioakeim-Ioannidou M; Yock TI; Shamberger RC; Mattei P; Vu L; Elhalawani H; Dusenbery KE; Vo KT; Huang MS; Friedmann AM; Diller LR; Marcus KJ; MacDonald SM; Terezakis SA; Braunstein SE; Hill-Kayser CE; Haas-Kogan DA
Radiother Oncol; 2024 Jun; 198():110384. PubMed ID: 38880415
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of local radiotherapy on growth and vertebral features in children with high-risk neuroblastoma.
Yang K; Ahn JH; Woo SY; Jung SH; Sung KW; Lee JW; Lim DH
BMC Pediatr; 2024 May; 24(1):372. PubMed ID: 38811872
[TBL] [Abstract][Full Text] [Related]
8. Osteochondroma in long-term survivors of high-risk neuroblastoma.
Kushner BH; Roberts SS; Friedman DN; Kuk D; Ostrovnaya I; Modak S; Kramer K; Basu EM; Cheung NK
Cancer; 2015 Jun; 121(12):2090-6. PubMed ID: 25728463
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma.
Davidoff AM
Semin Pediatr Surg; 2012 Feb; 21(1):2-14. PubMed ID: 22248965
[TBL] [Abstract][Full Text] [Related]
10. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
11. The role of surgery in the treatment of neuroblastoma metastases at rare sites.
Scherer S; Mayer BFB; Dietzel M; Esser M; Warmann SW; Lang P; Schuhmann MU; Schmidt A; Fuchs J
J Cancer Res Clin Oncol; 2023 Nov; 149(14):12913-12921. PubMed ID: 37466795
[TBL] [Abstract][Full Text] [Related]
12. Hyperbaric oxygen therapy as a complementary treatment in neuroblastoma - a narrative review.
Alpuim Costa D; Gonçalves-Nobre JG; Sampaio-Alves M; Guerra N; Arana Ribeiro J; Espiney Amaro C
Front Oncol; 2023; 13():1254322. PubMed ID: 37823059
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the role of radiotherapy in the treatment of neuroblastoma 4S: 30 years of institutional experience and systematic review.
Wawrzuta D; Chojnacka M; Dembowska-Bagińska B; Raciborska A; Hutnik Ł; Cieślak M; Pędziwiatr K
Clin Transl Radiat Oncol; 2024 Jul; 47():100791. PubMed ID: 38745962
[TBL] [Abstract][Full Text] [Related]
14. Advances in the Management of Neuroblastoma.
Qadir MI; Ahmed B; Noreen S
Crit Rev Eukaryot Gene Expr; 2024; 34(2):1-13. PubMed ID: 38073438
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of neuroblastoma: progress and promise beyond uncertainties.
Aravindan N; Natarajan M; Somasundaram DB; Aravindan S
J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 38249515
[TBL] [Abstract][Full Text] [Related]
16. The application and value of radiotherapy at the primary site in patients with high-risk neuroblastoma.
Wei Z; Li J; Jin Y; Liu Y; Wang P; Cao Y; Zhao Q
Br J Radiol; 2022 Jun; 95(1134):20211086. PubMed ID: 35312349
[TBL] [Abstract][Full Text] [Related]
17. Musculoskeletal outcomes and the effect of radiation to the vertebral bodies on growth trajectories for long-term survivors of high-risk neuroblastoma.
Ferris MJ; Tian S; Switchenko JM; Madden NA; Eaton BR; Esiashvili N
J Radiat Oncol; 2018 Jun; 7(2):187-193. PubMed ID: 34178250
[TBL] [Abstract][Full Text] [Related]
18. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.
Ferris MJ; Danish H; Switchenko JM; Deng C; George BA; Goldsmith KC; Wasilewski KJ; Cash WT; Khan MK; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):806-812. PubMed ID: 28244417
[TBL] [Abstract][Full Text] [Related]
19. Local Control With 21-Gy Radiation Therapy for High-Risk Neuroblastoma.
Casey DL; Kushner BH; Cheung NK; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):393-400. PubMed ID: 27473818
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
